An exhibit in the lobby of Green Library’s east wing titled “Undergraduate Showcase: The Senior Reflection in Biology” ...

Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...

Kyntra Bio(NASDAQ:KYNB) reported that its rebranding, asset sale, and debt payoff have shifted the company’s financial structure and enabled a clinical focus on oncology and rare disease. Management ...

Every year, Idaho State University hosts students from across all programs and disciplines to present their research. This includes undergraduate and graduate students, who are judged on their posters ...

Horses provide a strong translational model for human osteoarthritis -- Clinical investigation authorized by Belgian regulatory authority -- Allegro's hydrogel is first-in-class potentially ...

First-in-class immune-stimulating antibody conjugate BDC-4182 in Phase 1 dose escalation study, initial clinical data expected in 3Q 2026 Cash ...

Phallon Tullis-Joyce is squirting deer blood into the dirt. “Blood and water,” the Manchester United and United States ...

Microbiology professor Francis Maxin has taught at Community College of Allegheny County since it opened its doors 60 years ...

Nominated KRRO-121 development candidate for the potential treatment of hyperammonemia in patients with urea cycle disorders and hepatic ...

Explore 6 Maryland biotech companies with recent funding, ready to bring their breakthrough technologies to the clinic.

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...